Arkema | AKE - Sales Revenues

Stock Price
62.65
Daily Change
-0.80 -1.26%
Monthly
2.29%
Yearly
-6.77%
Q2 Forecast
61.20

Arkema reported EUR2.18B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Air Products & Chemicals USD 3.2B 100M Mar/2026
Air Liquide EUR 6.79B 6.43B Mar/2026
Akzo Nobel EUR 2.39B 20M Mar/2026
Arkema EUR 2.18B 70M Mar/2026
BASF EUR 16.02B 1.99B Mar/2026
Bayer EUR 13.41B 1.97B Mar/2026
Covestro EUR 2.92B 255M Dec/2025
Croda International GBP 825.73M 412.23M Dec/2025
Givaudan CHF 3.61B 256M Dec/2025
IMCD EUR 1.27B 170M Mar/2026
Johnson Matthey GBP 1.28B 4.76B Sep/2025
Kemira EUR 677M 13M Mar/2026
Lenzing EUR 615.7M 14.73M Mar/2026
Linde USD 8.76B 149M Dec/2025
PPG Industries USD 3.86B 50M Mar/2026
Sika AG CHF 5.52B 151.5M Dec/2025
Solvay EUR 997M 2M Mar/2026
Umicore EUR 10.68B 8.89B Dec/2025